R

Repare Therapeutics

174 employees

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$83M

from 8 investors over 8 rounds

R

Repare Therapeutics raised $83M on September 4, 2019

Investors: Versant Ventures, MPM Capital, Logos Global Management, LP, OrbiMed Advisors and Redmile Group

R

Repare Therapeutics raised $68M on June 22, 2017

Investors: MPM Capital, Celgene and Versant Ventures

FAQ